Prevalence of germline MUTYH mutations among Lynch-like syndrome patients.

[1]  I. Nagtegaal,et al.  Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. , 2014, Gastroenterology.

[2]  A. Chapelle,et al.  Biallelic MUTYH mutations can mimic Lynch syndrome , 2014, European Journal of Human Genetics.

[3]  Rodney J Scott,et al.  Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database , 2013, Nature Genetics.

[4]  J. Chang-Claude,et al.  Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility , 2013, PloS one.

[5]  W. Zheng,et al.  Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence , 2013, Gut.

[6]  H. Vasen,et al.  A hundred years of Lynch syndrome research (1913–2013) , 2013, Familial Cancer.

[7]  Á. Carracedo,et al.  Risk of cancer in cases of suspected lynch syndrome without germline mutation. , 2013, Gastroenterology.

[8]  P. Williamson,et al.  Colorectal Cancer in a Monoallelic MYH Mutation Carrier , 2013, Journal of Gastrointestinal Surgery.

[9]  P. Degan,et al.  Understanding the role of the Q338H MUTYH variant in oxidative damage repair , 2013, Nucleic acids research.

[10]  E. Kampman,et al.  Contribution of bi-allelic germline MUTYH mutations to early-onset and familial colorectal cancer and to low number of adenomatous polyps: case-series and literature review , 2013, Familial Cancer.

[11]  Yali Xie,et al.  Cancer-associated variants and a common polymorphism of MUTYH exhibit reduced repair of oxidative DNA damage using a GFP-based assay in mammalian cells. , 2012, Carcinogenesis.

[12]  J. Potter,et al.  Identification of Lynch syndrome among patients with colorectal cancer. , 2012, JAMA.

[13]  V. Moreno,et al.  Nanofluidic digital PCR for KRAS mutation detection and quantification in gastrointestinal cancer. , 2012, Clinical chemistry.

[14]  S. Gruber,et al.  MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study , 2012, European Journal of Human Genetics.

[15]  Aung Ko Win,et al.  Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer , 2011, International journal of cancer.

[16]  H. Morreau,et al.  MUTYH-associated polyposis (MAP). , 2011, Critical reviews in oncology/hematology.

[17]  M. Nielsen,et al.  MUTYH associated polyposis , 2011 .

[18]  MSH6 and MUTYH Deficiency Is a Frequent Event in Early-Onset Colorectal Cancer , 2010, Clinical Cancer Research.

[19]  W. Bodmer,et al.  MYH biallelic mutation can inactivate the two genetic pathways of colorectal cancer by APC or MLH1 transversions , 2010, Familial Cancer.

[20]  Antoni Castells,et al.  Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome. , 2010, The Journal of molecular diagnostics : JMD.

[21]  L. Påhlman,et al.  Common variants in human CRC genes as low-risk alleles. , 2010, European journal of cancer.

[22]  A. Carrato,et al.  Biallelic MYH germline mutations as cause of Muir-Torre syndrome , 2010, Familial Cancer.

[23]  Richard D Kolodner,et al.  Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. , 2009, Cancer research.

[24]  R. Houlston,et al.  Clinical implications of the colorectal cancer risk associated with MUTYH mutation. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  E. Jordanova,et al.  Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas , 2009, BMC Cancer.

[26]  J. Potter,et al.  Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. , 2009, Gastroenterology.

[27]  Á. Carracedo,et al.  Molecular analysis of the APC and MUTYH genes in Galician and Catalonian FAP families: a different spectrum of mutations? , 2009, BMC Medical Genetics.

[28]  A. Pollett,et al.  Pathological features of colorectal carcinomas in MYH‐associated polyposis , 2008, Histopathology.

[29]  H. Morreau,et al.  Identification of Patients with (Atypical) MUTYH-Associated Polyposis by KRAS2 c.34G > T Prescreening Followed by MUTYH Hotspot Analysis in Formalin-Fixed Paraffin-Embedded Tissue , 2008, Clinical Cancer Research.

[30]  H. Lynch,et al.  Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management , 2007, Familial Cancer.

[31]  J. Gisbert,et al.  Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[32]  H. Lynch,et al.  Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome). , 2007, Journal of the National Cancer Institute.

[33]  R. Ward,et al.  The role of MYH and microsatellite instability in the development of sporadic colorectal cancer , 2006, British Journal of Cancer.

[34]  M. Kloor,et al.  Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer , 2005, International journal of cancer.

[35]  A. Tenesa,et al.  Re: Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. , 2005, Journal of the National Cancer Institute.

[36]  L. Lipton,et al.  Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  S. Thibodeau,et al.  MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. , 2004, Gastroenterology.

[38]  A. Lu,et al.  Human MutY Homolog, a DNA Glycosylase Involved in Base Excision Repair, Physically and Functionally Interacts with Mismatch Repair Proteins Human MutS Homolog 2/Human MutS Homolog 6* , 2002, The Journal of Biological Chemistry.

[39]  Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study , 2001, British Journal of Cancer.

[40]  J. Garber,et al.  Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing. , 1999, JAMA.